How to translate text using browser tools
1 December 2016 TREATMENT OF RENAL CARCINOMA IN A BINTURONG (ARCTICTIS BINTURONG) WITH NEPHRECTOMY AND A TYROSINE KINASE INHIBITOR
Kimberly A. Thompson, Jon Patterson, Scott D. Fitzgerald, David Needle, Tara Harrison
Author Affiliations +
Abstract

A 13-yr-old female binturong (Arctictis binturong) presented with a 1 wk history of decreased appetite. The animal was thin, with hypercalcemia (calcium 12.2 mg/dl). A right renal mass was identified on ultrasound and removed via nephrectomy. Histopathology indicated a renal adenocarcinoma. Treatment with toceranib phosphate, a tyrosine-kinase inhibitor, was initiated and well tolerated by the animal. Four months after initial diagnosis radiographs indicated metastases to the lungs and the animal was euthanized. Necropsy revealed disseminated adenocarcinoma. Although treatment did not prevent metastasis, it was minimally invasive and well tolerated by the animal with minimal side effects. Review of records at the institution revealed that the cause of death for the primary case's dam and sire was disseminated renal carcinoma. These cases suggest that there may be a hereditary component to development of renal neoplasia in binturongs. Renal carcinoma should be considered an aggressive neoplasia in binturongs with a poor prognosis.

Copyright 2016 by American Association of Zoo Veterinarians
Kimberly A. Thompson, Jon Patterson, Scott D. Fitzgerald, David Needle, and Tara Harrison "TREATMENT OF RENAL CARCINOMA IN A BINTURONG (ARCTICTIS BINTURONG) WITH NEPHRECTOMY AND A TYROSINE KINASE INHIBITOR," Journal of Zoo and Wildlife Medicine 47(4), 1109-1113, (1 December 2016). https://doi.org/10.1638/2015-0285.1
Received: 14 December 2015; Published: 1 December 2016
KEYWORDS
Arctictis binturong
binturong
nephrectomy
renal adenocarcinoma
toceranib phosphate
tyrosine-kinase inhibitor
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top